The Journal of Allergy and Clinical Immunology
Volume 124, Issue 5 , Pages 990-996.e9 , November 2009

Levels of nitric oxide oxidation products are increased in the epithelial lining fluid of children with persistent asthma

  • Anne M. Fitzpatrick, PhD

      Affiliations

    • Department of Pediatrics, Emory University School of Medicine, Atlanta, Ga
    • Corresponding Author InformationReprint requests: Anne M. Fitzpatrick, PhD. 2015 Uppergate Dr, Atlanta, GA 30322.
    • ,
  • Lou Ann S. Brown, PhD

      Affiliations

    • Department of Pediatrics, Emory University School of Medicine, Atlanta, Ga
    • ,
  • Fernando Holguin, MD

      Affiliations

    • Department of Medicine, Emory University School of Medicine, Atlanta, Ga
    • ,
  • W. Gerald Teague, MD

      Affiliations

    • Department of Pediatrics, Emory University School of Medicine, Atlanta, Ga
    • ,
  • National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program

      Affiliations

    • See the acknowledgments for a complete listing of the Severe Asthma Research Program contributors.

Received 27 March 2009 ,Revised 5 August 2009 ,Accepted 25 August 2009.

References 

  1. Fitzpatrick AM, Gaston BM, Erzurum SC, Teague WG. Features of severe asthma in school-age children: Atopy and increased exhaled nitric oxide. J Allergy Clin Immunol. 2006;118:1218–1225
  2. Payne DNR, Adcock IM, Wilson NM, Oates T, Scallan M, Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med. 2001;164:1376–1381
  3. Bove PF, van der Vliet A. Nitric oxide and reactive nitrogen species in airway epithelial signaling and inflammation. Free Radical Biol Med. 2006;41:515–527
  4. Hausladen A, Privalle CT, Keng T, DeAngelo J, Stamler JS. Nitrosative stress: activation of the transcription factor OxyR. Cell. 1996;86:719–729
  5. Ghosh S, Janocha AJ, Aronica MA, Swaidani S, Comhair SA, Xu W, et al. Nitrotyrosine proteome survey identifies oxidative mechanism of catalase inactivation. J Immunol. 2006;176:5587–5597
  6. Saleh D, Ernst P, Lim S, Barnes PJ, Giaid A. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J. 1998;12:929–937
  7. van der Vliet A, Eiserich JP, O'Neill CA, Halliwell B, Cross CE. Tyrosine modification by reactive nitrogen species: a closer look. Arch Biochem Biophys. 1995;319:341–349
  8. Ratnawati , Morton J, Henry RL, Thomas PS. Exhaled breath condensate nitrite/nitrate and pH in relation to pediatric asthma control and exhaled nitric oxide. Pediatr Pulmonol. 2006;41:929–936
  9. Robroeks CMHHT, van de Kant KDG, Jobsis Q, Hendriks HJE, van Gent R, Wouters EFM, et al. Exhaled nitric oxide and biomarkers of exhaled breath condensate indicate the presence, severity and control of childhood asthma. Clin Exp Allergy. 2007;37:1303–1311
  10. Baraldi E, Giordano G, Pasquale MF, Carraro S, Mardegan A, Bonetto G, et al. 3-Nitrotyrosine, a marker of nitrosative stress, is increased in breath condensate of allergic asthmatic children. Allergy. 2006;61:90–96
  11. Dweik RA, Comhair SA, Gaston B, Thunnissen FB, Farver C, Thomassen MJ, et al. NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response. Proc Natl Acad Sci U S A. 2001;98:2622–2627
  12. MacPherson JPC, Comhair SA, Erzurum SC, Klein DF, Lipscomb MF, Kavuru MS, et al. Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species. J Immunol. 2001;166:5763–5772
  13. Fitzpatrick AM, Teague WG, Holguin F, Yeh M, Brown LAS. Airway glutathione homeostasis is altered in children with severe asthma: evidence for oxidant stress. J Allergy Clin Immunol. 2009;123:146–152
  14. National Heart, Lung and Blood Institute, National Asthma Education and Prevention Program. The NAEPP expert panel report: guidelines for the diagnosis and management of asthma—update on selected topics 2002. Bethesda: National Institutes of Health; 2002;Publication no. 02-5075
  15. American Thoracic Society. Lung function testing: selection of reference values and interpretive strategies. Am Rev Respir Dis. 1991;144:1202–1218
  16. American Thoracic Society. Proceedings of the American Thoracic Society Workshop on Refractory Asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med. 2000;162:2341–2351
  17. Payne D, McKenzie SA, Stacey S, Misra D, Haxby E, Bush A. Safety and ethics of bronchoscopy and endobronchial biopsy in difficult asthma. Arch Dis Child. 2001;84:423–426
  18. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–338
  19. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159:179–187
  20. American Thoracic Society and the European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171:912–930
  21. Rennard SI, Ghafouri M, Thompson AB, Linder J, Vaughan W, Jones K, et al. Fractional processing of sequential bronchoalveolar lavage to separate bronchial and alveolar samples. Am Rev Respir Dis. 1990;141:208–217
  22. Rennard SI, Basset G, Lecossier D, O'Donnell KM, Pinkston O, Martin PG, et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as a marker of dilution. J Appl Physiol. 1986;60:532–538
  23. Gaston B, Ratjen F, Vaughan JW, Malhotra NR, Canady RG, Snyder AH, et al. Nitrogen redox balance in the cystic fibrosis airway: effects of antipseudomonal therapy. Am J Respir Crit Care Med. 2002;165:387–390
  24. Xu W, Zheng S, Dweik RA, Erzurum SC. Role of epithelial nitric oxide in airway viral infection. Free Radic Biol Med. 2006;41:19–28
  25. Andreadis AA, Hazen SL, Comhair SA, Erzurum SC. Oxidative and nitrosative events in asthma. Free Radic Biol Med. 2003;35:213–225
  26. Stamler JS, Hausladen A. Oxidative modifications in nitrosative stress. Nat Struct Biol. 1998;5:247–249
  27. Fomanek W, Inci D, Lauener RP, Wildhaber JH, Frey U, Hall GL. Elevated nitrite in breath condensates of children with respiratory disease. Eur Respir J. 2002;19:487–491
  28. Kanazawa H, Nomura S, Hirata K, Yoshikawa J. Effect of inhaled beclomethasone dipropionate on peroxinitrite inhibitory activity in induced sputum from asthmatic patients. Chest. 2003;124:1755–1761
  29. Gaston B. Inhaled corticosteroid dose reduction in childhood asthma: is nitrosopnea informative?. Am J Respir Crit Care Med. 2005;171:1065–1066
  30. Berry M, Hargadon B, Morgan A, Shelley M, Richter J, Shaw D, et al. Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma. Eur Respir J. 2005;25:986–991
  31. Wegmann M, Fehrenbach H, Fehrenbach A, Held T, Schramm C, Garn H, et al. Involvement of distal airways in a chronic model of experimental asthma. Clin Exp Allergy. 2005;35:1263–1271
  32. Shin HW, Shelley DA, Henderson EM, Fitzpatrick A, Gaston B, George SC. Airway nitric oxide release is reduced after PBS inhalation in asthma. J Appl Physiol. 2007;102:1028–1033
  33. Jones SL, Herbison P, Cowan JO, Flannery EM, Hancox RJ, McLachlan CR, et al. Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship. Eur Resp J. 2002;60:601–608
  34. Travers J, Marsh S, Aldington S, Williams M, Shirtcliffe P, Pritchard A, et al. Reference ranges for exhaled nitric oxide derived from a random community survey of adults. Am J Respir Crit Care Med. 2007;176:238–242
  35. Lex C, Ferreira F, Zacharasiewicz , Nicholson AG, Haslam PL, Wilson NM, et al. Airway eosinophilia in children with severe asthma: predictive values of noninvasive tests. Am J Respir Crit Care Med. 2006;174:1286–1291
  36. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med. 2005;352:2163–2173
  37. Gaston B, Kelly R, Urban P, Liu L, Henderson EM, Doctor A, et al. Buffering airway acid decreases exhaled nitric oxide in asthma. J Allergy Clin Immunol. 2006;118:817–822
  38. Que LG, Liu L, Yan Y, Whitehead GS, Gavett SH, Schwartz DA, et al. Protection from experimental asthma by an endogenous bronchodilator. Science. 2005;308:1618–1621

 Supported with funds from National Institutes of Health/National Institute of Nursing Research KO1 NR010548, National Institutes of Health/National Center for Research Resources K12 RR017643, and National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program RO1 HL69170.

 Disclosure of potential conflict of interest: W. G. Teague is on the speakers' bureau for Merck and Co; receives research support from the National Institutes of Health/National Heart, Lung, and Blood Institute, the American Lung Association, and the Centers for Disease Control and Prevention; is on the review panel for the American Thoracic Society; and is on the advisory board for WESTAT–Children's Health Study. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(09)01321-9

doi: 10.1016/j.jaci.2009.08.039

The Journal of Allergy and Clinical Immunology
Volume 124, Issue 5 , Pages 990-996.e9 , November 2009

Article Tools

* Image Usage & Resolution